NEONC TECHNOLOGIES HOLDINGS, INC. Other General and Administrative Expense
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Other General and Administrative Expense of $569.95 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherGeneralAndAdministrativeExpense · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. other general and administrative expense for the quarter ending 2026-06-30 was $569.95K, a 3.99% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. other general and administrative expense for the quarter ending 2026-03-31 was $251.97K, a 75.36% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. other general and administrative expense for the quarter ending 2025-12-31 was $1.73M, a 1333.45% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. other general and administrative expense for the quarter ending 2025-09-30 was $532.36K, a 110.13% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. other general and administrative expense for fiscal 2025 was $2.99M, a 254.66% increase from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. other general and administrative expense for fiscal 2024 was $842.26K.
| Period end | Other General and Administrative Expense 3 month | Other General and Administrative Expense 6 month | Other General and Administrative Expense 9 month | Other General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $569.95K 10-Q · filed 2026-08-10 | $821.92K 10-Q · filed 2026-08-10 | $2.55M derived: sum of 3 quarters · filed 2026-08-10 | $3.08M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $251.97K 10-Q · filed 2026-05-15 | $1.98M derived: sum of 2 quarters · filed 2026-05-15 | $2.51M derived: sum of 3 quarters · filed 2026-05-15 | $3.10M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.26M derived: sum of 2 quarters · filed 2026-03-31 | $2.85M derived: sum of 3 quarters · filed 2026-08-10 | $2.99M 10-K · filed 2026-03-31 |
| 2025-09-30 | $532.36K 10-Q · filed 2025-11-14 | $1.13M derived: sum of 2 quarters · filed 2026-08-10 | $1.26M 10-Q · filed 2025-11-14 | $1.39M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $593.61K 10-Q · filed 2026-08-10 | $728.51K 10-Q · filed 2026-08-10 | $857.72K derived: sum of 3 quarters · filed 2026-08-10 | $1.11M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $143.68K 10-Q · filed 2026-05-15 | $264.11K derived: sum of 2 quarters · filed 2026-05-15 | $517.46K derived: sum of 3 quarters · filed 2026-05-15 | $723.32K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $120.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $373.77K derived: sum of 2 quarters · filed 2026-03-31 | $579.63K derived: sum of 3 quarters · filed 2026-03-31 | $842.26K 10-K · filed 2026-03-31 |
| 2024-09-30 | $253.35K 10-Q · filed 2025-11-14 | $459.21K derived: sum of 2 quarters · filed 2025-11-14 | $721.83K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $205.86K 10-Q · filed 2025-08-18 | $466.08K 10-Q · filed 2025-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |